Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons.

Section on Neural Development and Plasticity, National Institute of Child Health and Human Development, Bethesda, Maryland, USA.
Nature Neuroscience (Impact Factor: 14.98). 02/2010; 13(3):302-9. DOI: 10.1038/nn.2505
Source: PubMed

ABSTRACT Extracellular factors may act on cells in two distinct modes: an acute increase in concentration as a result of regulated secretion, or a gradual increase in concentration when secreted constitutively or from a distant source. We found that cellular responses to brain-derived neurotrophic factor (BDNF) differed markedly depending on how BDNF was delivered. In cultured rat hippocampal neurons, acute and gradual increases in BDNF elicited transient and sustained activation of TrkB receptor and its downstream signaling, respectively, leading to differential expression of Homer1 and Arc. Transient TrkB activation promoted neurite elongation and spine head enlargement, whereas sustained TrkB activation facilitated neurite branch and spine neck elongation. In hippocampal slices, fast and slow increases in BDNF enhanced basal synaptic transmission and LTP, respectively. Thus, the kinetics of TrkB activation is critical for cell signaling and functions. This temporal dimension in cellular signaling may also have implications for the therapeutic drug design.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Human Bone marrow stromal cells (hBMSCs) can differentiate under appropriate experimental conditions into neuronal and glial-like cells. This study shows a protocol for producing human neural stem cells (hNSCs) from hBMSCs and the subsequent differentiation of hNSCs into cholinergic neurons (CNs), where sequential media replaced the culturing media. hBMSCs have been used in generating cell aggregates (CAs) using bFGF, EGF and B27. The hNSCs were isolated from CAs, and the CNs differentiated from the hNSCs using sequential media, where bFGF, EGF and B27 were gradually replaced with NGF. The hNSC stemness was checked by RT-PCR of SOX2, Oct-4 and Nanog genes. Fibronectin, CD90, CD106, CD31, nestin, neurofilament 68 (NF-68), NF-200 and ChAT immunostaining evaluated the differentiation of the hBMSCs, the hNSCs and the CNs. FM1-43 was used in studying the function of the CNs. The hBMSCs were immunoreactive to fibronectin, CD90 and CD106; they were checked for lipogenic and osteogenic differentiation. The cells of the CAs were immunoreactive to nestin. The hNSCs were immunoreactive to nestin and NF-68, also, they expressed SOX2, Oct-4 and nanong. Nestin expression declined sharply following NSC differentiation into CNs, while the expression of NF-200, synapsin I, synaptophysin, MAP-2 and ChAT increased. They were stained with FM1-43, where the synaptic vesicles were released following stimulation. The present study demonstrates the conversion of hBMSCs into CASs under appropriate conditions. CAs generated hNSCs, which were induced in order to differentiate into CNs using sequential media, where the yield was 83%.
    Fetal ovine model for in-situ esophagus tissue engineering 12/2014; 12(1). DOI:10.1007/s13770-014-0019-6 · 0.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Brain-derived neurotrophic factor (BDNF) attracts increasing attention from both research and clinical fields because of its important functions in the central nervous system. An adequate amount of BDNF is critical to develop and maintain normal neuronal circuits in the brain. Given that loss of BDNF function has been reported in the brains of patients with neurodegenerative or psychiatric diseases, understanding basic properties of BDNF and associated intracellular processes is imperative. In this review, we revisit the gene structure, transcription, translation, transport and secretion mechanisms of BDNF. We also introduce implications of BDNF in several brain-related diseases including Alzheimer's disease, Huntington's disease, depression and schizophrenia.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The pathogenic mechanisms underlying neuropathic pain still remain largely unknown. In this study, we investigated whether spinal BDNF contributes to dorsal horn LTP induction and neuropathic pain development by activation of GluN2B-NMDA receptors via Src homology-2 domain-containing protein tyrosine phosphatase-2 (SHP2) phosphorylation in rats following spinal nerve ligation (SNL). We first demonstrated that spinal BDNF participates in the development of long-lasting hyperexcitability of dorsal horn WDR neurons (i.e. central sensitization) as well as pain allodynia in both intact and SNL rats. Second, we revealed that BDNF induces spinal LTP at C-fiber synapses via functional up-regulation of GluN2B-NMDA receptors in the spinal dorsal horn, and this BDNF-mediated LTP-like state is responsible for the occlusion of spinal LTP elicited by subsequent high-frequency electrical stimulation (HFS) of the sciatic nerve in SNL rats. Finally, we validated that BDNF-evoked SHP2 phosphorylation is required for subsequent GluN2B-NMDA receptors up-regulation and spinal LTP induction, and also for pain allodynia development. Blockade of SHP2 phosphorylation in the spinal dorsal horn using a potent SHP2 protein tyrosine phosphatase inhibitor NSC-87877, or knockdown of spinal SHP2 by intrathecal delivery of SHP2 siRNA, not only prevents BDNF-mediated GluN2B-NMDA receptors activation as well as spinal LTP induction and pain allodynia elicitation in intact rats, but also reduces the SNL-evoked GluN2B-NMDA receptors up-regulation and spinal LTP occlusion, and ultimately alleviates pain allodynia in neuropathic rats. Taken together, these results suggest that the BDNF/SHP2/GluN2B-NMDA signaling cascade plays a vital role in the development of central sensitization and neuropathic pain after peripheral nerve injury. Copyright © 2014 Elsevier Inc. All rights reserved.
    Neurobiology of Disease 11/2014; 73C:428-451. DOI:10.1016/j.nbd.2014.10.025 · 5.20 Impact Factor

Full-text (2 Sources)

Available from
Jun 1, 2014